Skip to content

Effect of Remote Ischaemic Preconditioning on Renal Function in Patients Undergoing Living Donor Kidney Transplantation

Effect of Lower Limb Ischaemic Preconditioning on Renal Function in Patients Undergoing Living Donor Kidney Transplantation

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01289548
Enrollment
120
Registered
2011-02-03
Start date
2010-05-31
Completion date
2012-01-31
Last updated
2013-09-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kidney Diseases, Kidney Failure, Kidney Failure, Chronic, Renal Insufficiency, Renal Insufficiency, Chronic, Urologic Diseases

Keywords

remote ischaemic preconditioning, kidney transplantation

Brief summary

The purpose of this study was to investigate whether lower limb ischaemic preconditioning can improve renal function in patients undergoing living donor kidney transplantation

Detailed description

Ischemia reperfusion injury (IRI) induced renal failure after kidney transplantation is a common clinical problem associated with a high morbidity and mortality. To reduce the adverse effects of IRI after organ transplantation various strategies aimed at the different pathophysiological processes of IRI have been investigated. Remote ischemic preconditioning (RIPC) is one such strategy where brief IRI of one organ protects other organs from sustained IRI. Many studies have shown that RIPC protects heart, muscle flaps, stomach, liver, lungs, and kidneys from IRI. RIPC of the limb with a tourniquet is a safe and convenient method of preconditioning organs against IRI. However, the efficacy of RIPC in patients undergoing living donor kidney transplantation need to be established and mechanism of early and late RIPC, such as whether the donor should undergo remote preconditioning or the recipient, need to be investigated.

Interventions

Remote ischaemic preconditioning consisted of three 5-min cycles of left lower limb ischaemia, which was induced by an automated cuff-inflator placed on the left lower limb and inflated to 300 mm Hg, with an intervening 5 min of reperfusion during which the cuff was deflated.

Sponsors

B. Braun Medical SA
CollaboratorINDUSTRY
Huazhong University of Science and Technology
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Subject capable of giving written informed consent, with end-stage kidney disease, who is a suitable candidate for primary kidney transplantation * Living donors * Compatible ABO blood type * PRA \< 20%

Exclusion criteria

* Re-transplant patients * Those with peripheral vascular disease affecting the lower limbs

Design outcomes

Primary

MeasureTime frameDescription
Plasma Creatine Concentration of the Recipientswithin the first 3days after the operationPlasma creatinine concentration before surgery, 1hour, 4hours, 24hours, 48hours and 72hours after the artery unclamping
Urinary Output of the Recipients Postoperativelywithin the first 3days after the operationAccumulated urinary output 1hour, 4hours and 24hours after the artery unclamping and the urinary output on the 2nd and 3rd day after the operation
Plasma Concentration of NGAL in the Recipientswithin the first 24hours after the operationPlasma concentration of neutrophil gelatinase-associated lipocalin (NGAL) before the operation and 24hours after the artery unclamping

Secondary

MeasureTime frameDescription
Acute Rejection of Transplanted Kidneybefore dischargebiopsy-confirmed, clinically symptomatic
Delayed Graft Functionbefore dischargeDelayed Graft Function according to the clinical symptoms
Urine Concentration of NAG Postoperatively in Recipientswithin the first 24hours after the artery unclampingUrine concentration of N-acetyl-D-glucosaminidase (NAG) 1hour, 4hours and 24hours after the artery unclamping in the recipients
Urine Concentration of RBP Preoperatively in the Recipientsbefore the operationUrine concentration of retinol binding protein (RBP) before the operation in the recipients
Urine Concentration of RBP Postoperatively in the Recipientswithin the first 24hours after the artery unclampingUrine concentration of retinol binding protein (RBP) 1hour, 4hours and 24hours after the artery unclamping in the recipients
Length of Postoperative Hospital Staybefore dischargetime from the day of operation to the day of discharge for the recipients
Total Costs During the Hospitalizationfrom the admission to the discharge of the patientsTotal costs from the admission to the discharge of the recipients
Urine Concentration of NAG Preoperatively in Recipientsbefore operationUrine concentration of N-acetyl-D-glucosaminidase (NAG) before the operation
Plasma Concentration of SOD in the Recipientswithin 24hours after the operationPlasma concentration of superoxide dismutase (SOD) before the operation, 1hour, 4hours and 24hours after the artery unclamping in the recipients
Plasma Concentration of MDA in the Recipientswithin the first 24hours after the operationPlasma concentration of malondialdehyde (MDA) before the operation, 1hour, 4hours and 24hours after the artery unclamping in the recipients

Countries

China

Participant flow

Recruitment details

Patients scheduled for living donor renal transplantation in the Department of Transplantation, Tongji Hospital, Huazhong University of Science and Technology were recruited in the project from May 2010 to November 2011.

Pre-assignment details

68 pairs of patients were enrolled during the recruitment period. among them, 5 recipients had the history of renal transplantation before; 2 recipients had concomitant diabetes mellitus; and another one recipient had severe varicose vein in his lower limb. The left 60 pairs of donors and recipients (120 in total) were finally assigned to groups.

Participants by arm

ArmCount
Control
patients (both donors and recipients) had a deflated cuff placed on the left lower limb for 30 min.
20
Donor + RIPC
Donors receive remote ischaemic preconditioning after anaesthesia induction and before surgery started; recipients only have a deflated blood pressure cuff around their leg for 30 minutes.
20
Recipient +RIPC
recipients receive remote ischaemic preconditioning after anaesthesia induction and before surgery started; donors only have a deflated blood pressure cuff around their leg for 30 minutes.
20
Total60

Baseline characteristics

CharacteristicDonor + RIPCRecipient +RIPCTotalControl
Age Continuous47.4 years
STANDARD_DEVIATION 10
48.7 years
STANDARD_DEVIATION 5.2
47.6 years
STANDARD_DEVIATION 7.4
32.5 years
STANDARD_DEVIATION 10.3
Body mass index (BMI)19.94 kg/m^2
STANDARD_DEVIATION 1.99
20.38 kg/m^2
STANDARD_DEVIATION 3.2
20.13 kg/m^2
STANDARD_DEVIATION 2.65
22.19 kg/m^2
STANDARD_DEVIATION 3.51
Cold ischemic time166.25 minutes
STANDARD_DEVIATION 19.22
177.25 minutes
STANDARD_DEVIATION 27.59
173.05 minutes
STANDARD_DEVIATION 28.52
175.65 minutes
STANDARD_DEVIATION 36.35
Region of Enrollment
China
20 donors/recipients pairs20 donors/recipients pairs60 donors/recipients pairs20 donors/recipients pairs
Relationship
parents
16 donors/recipients pairs14 donors/recipients pairs42 donors/recipients pairs12 donors/recipients pairs
Relationship
siblings
2 donors/recipients pairs5 donors/recipients pairs13 donors/recipients pairs6 donors/recipients pairs
Relationship
spouses
2 donors/recipients pairs1 donors/recipients pairs5 donors/recipients pairs2 donors/recipients pairs
Sex: Female, Male
Female
14 Participants6 Participants14 Participants4 Participants
Sex: Female, Male
Male
6 Participants10 Participants24 Participants8 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
— / —— / —— / —
other
Total, other adverse events
0 / 400 / 400 / 40
serious
Total, serious adverse events
0 / 400 / 400 / 40

Outcome results

Primary

Plasma Concentration of NGAL in the Recipients

Plasma concentration of neutrophil gelatinase-associated lipocalin (NGAL) before the operation and 24hours after the artery unclamping

Time frame: within the first 24hours after the operation

Population: All patients completed the trial and no dropout occured.

ArmMeasureGroupValue (MEDIAN)Dispersion
ControlPlasma Concentration of NGAL in the Recipientsbefore operation1478.7 ng/mlInter-Quartile Range 617.65
ControlPlasma Concentration of NGAL in the Recipients24hours after the artery unclamping317.8 ng/mlInter-Quartile Range 210.41
Donor + RIPCPlasma Concentration of NGAL in the Recipientsbefore operation1269.1 ng/mlInter-Quartile Range 603.1
Donor + RIPCPlasma Concentration of NGAL in the Recipients24hours after the artery unclamping370.1 ng/mlInter-Quartile Range 212.51
Recipient +RIPCPlasma Concentration of NGAL in the Recipientsbefore operation1377.9 ng/mlInter-Quartile Range 677.98
Recipient +RIPCPlasma Concentration of NGAL in the Recipients24hours after the artery unclamping256.2 ng/mlInter-Quartile Range 309.04
Primary

Plasma Creatine Concentration of the Recipients

Plasma creatinine concentration before surgery, 1hour, 4hours, 24hours, 48hours and 72hours after the artery unclamping

Time frame: within the first 3days after the operation

Population: All patients completed the trial and no dropout occured.

ArmMeasureGroupValue (MEDIAN)Dispersion
ControlPlasma Creatine Concentration of the Recipientsbefore operation849.5 μmol/lInter-Quartile Range 122.34
ControlPlasma Creatine Concentration of the Recipients1hour after the artery unclamping776.5 μmol/lInter-Quartile Range 102.74
ControlPlasma Creatine Concentration of the Recipients4hours after the artery unclamping651.5 μmol/lInter-Quartile Range 118.27
ControlPlasma Creatine Concentration of the Recipients24hours after the artery unclamping222.5 μmol/lInter-Quartile Range 102.44
ControlPlasma Creatine Concentration of the Recipients48hours after the artery unclamping150.0 μmol/lInter-Quartile Range 80.35
ControlPlasma Creatine Concentration of the Recipients72hours after the artery unclamping120 μmol/lInter-Quartile Range 48.25
Donor + RIPCPlasma Creatine Concentration of the Recipients72hours after the artery unclamping153.0 μmol/lInter-Quartile Range 73.61
Donor + RIPCPlasma Creatine Concentration of the Recipientsbefore operation878.5 μmol/lInter-Quartile Range 258.41
Donor + RIPCPlasma Creatine Concentration of the Recipients24hours after the artery unclamping240.5 μmol/lInter-Quartile Range 92.51
Donor + RIPCPlasma Creatine Concentration of the Recipients48hours after the artery unclamping193.5 μmol/lInter-Quartile Range 74.69
Donor + RIPCPlasma Creatine Concentration of the Recipients1hour after the artery unclamping797.5 μmol/lInter-Quartile Range 231.99
Donor + RIPCPlasma Creatine Concentration of the Recipients4hours after the artery unclamping639.0 μmol/lInter-Quartile Range 226.72
Recipient +RIPCPlasma Creatine Concentration of the Recipients1hour after the artery unclamping725.5 μmol/lInter-Quartile Range 182.56
Recipient +RIPCPlasma Creatine Concentration of the Recipients4hours after the artery unclamping600.5 μmol/lInter-Quartile Range 213.39
Recipient +RIPCPlasma Creatine Concentration of the Recipients72hours after the artery unclamping126.5 μmol/lInter-Quartile Range 71.78
Recipient +RIPCPlasma Creatine Concentration of the Recipients24hours after the artery unclamping253.5 μmol/lInter-Quartile Range 121.4
Recipient +RIPCPlasma Creatine Concentration of the Recipientsbefore operation771.0 μmol/lInter-Quartile Range 205.4
Recipient +RIPCPlasma Creatine Concentration of the Recipients48hours after the artery unclamping176.5 μmol/lInter-Quartile Range 96.18
Primary

Urinary Output of the Recipients Postoperatively

Accumulated urinary output 1hour, 4hours and 24hours after the artery unclamping and the urinary output on the 2nd and 3rd day after the operation

Time frame: within the first 3days after the operation

Population: All patients completed the trial and no dropout occured.

ArmMeasureGroupValue (MEDIAN)Dispersion
ControlUrinary Output of the Recipients Postoperativelyon the 3rd day after the operation4600 mlInter-Quartile Range 1215.9
ControlUrinary Output of the Recipients Postoperativelywithin 4hours after the artery unclamping1875 mlInter-Quartile Range 1502.7
ControlUrinary Output of the Recipients Postoperativelywithin 24hours after the artery unclamping8775 mlInter-Quartile Range 5289.8
ControlUrinary Output of the Recipients Postoperativelywithin 1hour after the artery unclamping175 mlInter-Quartile Range 265.1
ControlUrinary Output of the Recipients Postoperativelyon the 2nd day after the operation5355 mlInter-Quartile Range 2051.7
Donor + RIPCUrinary Output of the Recipients Postoperativelywithin 4hours after the artery unclamping2650 mlInter-Quartile Range 1271.9
Donor + RIPCUrinary Output of the Recipients Postoperativelyon the 2nd day after the operation5200 mlInter-Quartile Range 3846.3
Donor + RIPCUrinary Output of the Recipients Postoperativelyon the 3rd day after the operation3765 mlInter-Quartile Range 2166.7
Donor + RIPCUrinary Output of the Recipients Postoperativelywithin 1hour after the artery unclamping300 mlInter-Quartile Range 239.6
Donor + RIPCUrinary Output of the Recipients Postoperativelywithin 24hours after the artery unclamping10025 mlInter-Quartile Range 5151
Recipient +RIPCUrinary Output of the Recipients Postoperativelyon the 3rd day after the operation3650 mlInter-Quartile Range 1451.5
Recipient +RIPCUrinary Output of the Recipients Postoperativelywithin 4hours after the artery unclamping1850 mlInter-Quartile Range 999.8
Recipient +RIPCUrinary Output of the Recipients Postoperativelywithin 24hours after the artery unclamping6375 mlInter-Quartile Range 3497
Recipient +RIPCUrinary Output of the Recipients Postoperativelyon the 2nd day after the operation4020 mlInter-Quartile Range 1984.5
Recipient +RIPCUrinary Output of the Recipients Postoperativelywithin 1hour after the artery unclamping100 mlInter-Quartile Range 220.4
Secondary

Acute Rejection of Transplanted Kidney

biopsy-confirmed, clinically symptomatic

Time frame: before discharge

Population: All the patients completed the study and no dropout occured.

ArmMeasureValue (NUMBER)
ControlAcute Rejection of Transplanted Kidney0 participants
Donor + RIPCAcute Rejection of Transplanted Kidney0 participants
Recipient +RIPCAcute Rejection of Transplanted Kidney0 participants
Secondary

Delayed Graft Function

Delayed Graft Function according to the clinical symptoms

Time frame: before discharge

Population: All the patients completed the study and no dropout occured.

ArmMeasureValue (NUMBER)
ControlDelayed Graft Function1 participants
Donor + RIPCDelayed Graft Function2 participants
Recipient +RIPCDelayed Graft Function2 participants
Secondary

Length of Postoperative Hospital Stay

time from the day of operation to the day of discharge for the recipients

Time frame: before discharge

Population: All the patients completed the study and no dropout occured.

ArmMeasureValue (MEDIAN)Dispersion
ControlLength of Postoperative Hospital Stay17 dayInter-Quartile Range 4.8
Donor + RIPCLength of Postoperative Hospital Stay15 dayInter-Quartile Range 3.7
Recipient +RIPCLength of Postoperative Hospital Stay14.5 dayInter-Quartile Range 8.2
Secondary

Plasma Concentration of MDA in the Recipients

Plasma concentration of malondialdehyde (MDA) before the operation, 1hour, 4hours and 24hours after the artery unclamping in the recipients

Time frame: within the first 24hours after the operation

Population: All patients completed the trial and no dropout occured.

ArmMeasureGroupValue (MEDIAN)Dispersion
ControlPlasma Concentration of MDA in the Recipients1hour after the artery unclamping3.58 nmol/mlInter-Quartile Range 0.8
ControlPlasma Concentration of MDA in the Recipientsbefore operation2.96 nmol/mlInter-Quartile Range 0.72
ControlPlasma Concentration of MDA in the Recipients4hours after the artery unclamping3.60 nmol/mlInter-Quartile Range 0.8
ControlPlasma Concentration of MDA in the Recipients24hours after the artery unclamping2.97 nmol/mlInter-Quartile Range 0.88
Donor + RIPCPlasma Concentration of MDA in the Recipientsbefore operation3.34 nmol/mlInter-Quartile Range 0.7
Donor + RIPCPlasma Concentration of MDA in the Recipients4hours after the artery unclamping3.46 nmol/mlInter-Quartile Range 0.92
Donor + RIPCPlasma Concentration of MDA in the Recipients24hours after the artery unclamping3.57 nmol/mlInter-Quartile Range 0.72
Donor + RIPCPlasma Concentration of MDA in the Recipients1hour after the artery unclamping4.15 nmol/mlInter-Quartile Range 0.59
Recipient +RIPCPlasma Concentration of MDA in the Recipients24hours after the artery unclamping3.36 nmol/mlInter-Quartile Range 0.83
Recipient +RIPCPlasma Concentration of MDA in the Recipients4hours after the artery unclamping3.54 nmol/mlInter-Quartile Range 0.84
Recipient +RIPCPlasma Concentration of MDA in the Recipients1hour after the artery unclamping3.91 nmol/mlInter-Quartile Range 0.77
Recipient +RIPCPlasma Concentration of MDA in the Recipientsbefore operation3.14 nmol/mlInter-Quartile Range 0.65
Secondary

Plasma Concentration of SOD in the Recipients

Plasma concentration of superoxide dismutase (SOD) before the operation, 1hour, 4hours and 24hours after the artery unclamping in the recipients

Time frame: within 24hours after the operation

Population: All patients completed the trial and no dropout occured.

ArmMeasureGroupValue (MEDIAN)Dispersion
ControlPlasma Concentration of SOD in the Recipientsbefore operation105.04 U/mlInter-Quartile Range 27.08
ControlPlasma Concentration of SOD in the Recipients24hours after the artery unclamping41.47 U/mlInter-Quartile Range 33.83
ControlPlasma Concentration of SOD in the Recipients4hours after the artery unclamping76.47 U/mlInter-Quartile Range 28.81
ControlPlasma Concentration of SOD in the Recipients1hour after the artery unclamping88.86 U/mlInter-Quartile Range 21.41
Donor + RIPCPlasma Concentration of SOD in the Recipients1hour after the artery unclamping94.90 U/mlInter-Quartile Range 28.96
Donor + RIPCPlasma Concentration of SOD in the Recipients4hours after the artery unclamping90.67 U/mlInter-Quartile Range 32.49
Donor + RIPCPlasma Concentration of SOD in the Recipients24hours after the artery unclamping64.13 U/mlInter-Quartile Range 34.99
Donor + RIPCPlasma Concentration of SOD in the Recipientsbefore operation96.77 U/mlInter-Quartile Range 29.79
Recipient +RIPCPlasma Concentration of SOD in the Recipients24hours after the artery unclamping68.04 U/mlInter-Quartile Range 29.27
Recipient +RIPCPlasma Concentration of SOD in the Recipientsbefore operation113.51 U/mlInter-Quartile Range 23.86
Recipient +RIPCPlasma Concentration of SOD in the Recipients4hours after the artery unclamping89.36 U/mlInter-Quartile Range 22.47
Recipient +RIPCPlasma Concentration of SOD in the Recipients1hour after the artery unclamping112.25 U/mlInter-Quartile Range 23.92
Secondary

Total Costs During the Hospitalization

Total costs from the admission to the discharge of the recipients

Time frame: from the admission to the discharge of the patients

Population: All the patients completed the study and no dropout occured.

ArmMeasureValue (MEDIAN)Dispersion
ControlTotal Costs During the Hospitalization82499 RMB yuanInter-Quartile Range 23625.18
Donor + RIPCTotal Costs During the Hospitalization83574 RMB yuanInter-Quartile Range 22164.7
Recipient +RIPCTotal Costs During the Hospitalization82298 RMB yuanInter-Quartile Range 24113.99
Secondary

Urine Concentration of NAG Postoperatively in Recipients

Urine concentration of N-acetyl-D-glucosaminidase (NAG) 1hour, 4hours and 24hours after the artery unclamping in the recipients

Time frame: within the first 24hours after the artery unclamping

Population: All patients completed the trial and no dropout occured.

ArmMeasureGroupValue (MEDIAN)Dispersion
ControlUrine Concentration of NAG Postoperatively in Recipients4hours after the artery unclamping3.74 U/LInter-Quartile Range 3.27
ControlUrine Concentration of NAG Postoperatively in Recipients1hour after the artery unclamping16.58 U/LInter-Quartile Range 26.94
ControlUrine Concentration of NAG Postoperatively in Recipients24hours after the artery unclamping3.73 U/LInter-Quartile Range 7.36
Donor + RIPCUrine Concentration of NAG Postoperatively in Recipients4hours after the artery unclamping4.45 U/LInter-Quartile Range 10.37
Donor + RIPCUrine Concentration of NAG Postoperatively in Recipients1hour after the artery unclamping18.54 U/LInter-Quartile Range 29.58
Donor + RIPCUrine Concentration of NAG Postoperatively in Recipients24hours after the artery unclamping2.65 U/LInter-Quartile Range 3.01
Recipient +RIPCUrine Concentration of NAG Postoperatively in Recipients1hour after the artery unclamping17.06 U/LInter-Quartile Range 31.3
Recipient +RIPCUrine Concentration of NAG Postoperatively in Recipients24hours after the artery unclamping4.13 U/LInter-Quartile Range 2.87
Recipient +RIPCUrine Concentration of NAG Postoperatively in Recipients4hours after the artery unclamping6.46 U/LInter-Quartile Range 6.92
Secondary

Urine Concentration of NAG Preoperatively in Recipients

Urine concentration of N-acetyl-D-glucosaminidase (NAG) before the operation

Time frame: before operation

Population: Urine could not be obtained from the other 46 patients because of anuria.

ArmMeasureValue (MEAN)Dispersion
ControlUrine Concentration of NAG Preoperatively in Recipients20.79 U/LStandard Deviation 13.68
Donor + RIPCUrine Concentration of NAG Preoperatively in Recipients15.25 U/LStandard Deviation 0
Recipient +RIPCUrine Concentration of NAG Preoperatively in Recipients16.09 U/LStandard Deviation 20.71
Secondary

Urine Concentration of RBP Postoperatively in the Recipients

Urine concentration of retinol binding protein (RBP) 1hour, 4hours and 24hours after the artery unclamping in the recipients

Time frame: within the first 24hours after the artery unclamping

Population: All patients completed the trial and no dropout occured.

ArmMeasureGroupValue (MEDIAN)Dispersion
ControlUrine Concentration of RBP Postoperatively in the Recipients4hours after the artery unclamping2.23 mg/LInter-Quartile Range 0.28
ControlUrine Concentration of RBP Postoperatively in the Recipients1hour after the artery unclamping2.18 mg/LInter-Quartile Range 0.44
ControlUrine Concentration of RBP Postoperatively in the Recipients24hours after the artery unclamping2.05 mg/LInter-Quartile Range 0.48
Donor + RIPCUrine Concentration of RBP Postoperatively in the Recipients4hours after the artery unclamping1.94 mg/LInter-Quartile Range 0.48
Donor + RIPCUrine Concentration of RBP Postoperatively in the Recipients1hour after the artery unclamping1.93 mg/LInter-Quartile Range 0.42
Donor + RIPCUrine Concentration of RBP Postoperatively in the Recipients24hours after the artery unclamping1.91 mg/LInter-Quartile Range 0.43
Recipient +RIPCUrine Concentration of RBP Postoperatively in the Recipients1hour after the artery unclamping2.05 mg/LInter-Quartile Range 0.44
Recipient +RIPCUrine Concentration of RBP Postoperatively in the Recipients24hours after the artery unclamping1.94 mg/LInter-Quartile Range 0.5
Recipient +RIPCUrine Concentration of RBP Postoperatively in the Recipients4hours after the artery unclamping2.27 mg/LInter-Quartile Range 0.56
Secondary

Urine Concentration of RBP Preoperatively in the Recipients

Urine concentration of retinol binding protein (RBP) before the operation in the recipients

Time frame: before the operation

Population: No urine could be obtained from the other 46 patients because of anuria.

ArmMeasureValue (MEAN)Dispersion
ControlUrine Concentration of RBP Preoperatively in the Recipients2.222 mg/LStandard Deviation 0.315
Donor + RIPCUrine Concentration of RBP Preoperatively in the Recipients2.168 mg/LStandard Deviation 0
Recipient +RIPCUrine Concentration of RBP Preoperatively in the Recipients1.964 mg/LStandard Deviation 0.465

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026